Literature DB >> 952997

Lesions in post-ribosomal supernatant fractions associated with loss of viability in pea (Pisum arvense) seed.

C M Bray, T Y Chow.   

Abstract

RNA synthesis and protein synthesis in viable pea embryonic axis tissue commences during the first hour of water imbibition whilst DNA synthesis commences after 8 h of imbibition. Neither DNA synthesis nor protein synthesis could be detected in non-viable axis tissue during the first 24 h of imbibition but some RNA synthesis is detectable during this period. Both post-ribosomal supernatant and ribosomal fractions from imbibed non-viable embryonic axis tissue were impaired in their ability to support polyphenylalanine synthesis in a cell-free protein-synthesising system, yet the same fractions isolated from unimbibed non-viable axis tissue were as efficient as equivalent fractions from unimbibed viable axis tissue in the support of polyphenylalanine synthesis in the cell-free system. A major lesion in elongation factor 1 activity and additional lesions in elongation factor 2 and phenylalanyl-tRNA synthetase activities were detected in the post-ribosomal supernatants isolated from non-viable embryonic axis tissue.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 952997     DOI: 10.1016/0005-2787(76)90169-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Decline in ribonucleic acid and protein synthesis with loss of viability during the early hours of imbibition of rye (Secale cereale L.) embryos.

Authors:  S Sen; D J Osborne
Journal:  Biochem J       Date:  1977-07-15       Impact factor: 3.857

2.  Ribonucleic acid synthesis and loss of viability in pea seed.

Authors:  C M Bray; J Dasgupta
Journal:  Planta       Date:  1976-01       Impact factor: 4.116

3.  Membrene turnover in imbibed and dormant embryos of the wild oat (Avena fatua L.) : I. Protein turnover and membrane replacement.

Authors:  A C Cuming; D J Osborne
Journal:  Planta       Date:  1978-01       Impact factor: 4.116

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.